Latest available resultsQuarter ended March 31, 202610-Q · May 5, 2026
Filed with the SECIQVIA HOLDINGS INC.
IQVHealthcare
Results announcedJuly 28, 2026▲ +2.9%
Detailed filing pendingNext reportOctober 26, 2026pre-market · Analyst forecast 3.306 $/share
Revenue
$4.15B
▲ +8.4% vs prior year% YoY
Net income
$274.00M
▲ +10.0% vs prior year% YoY
EPS
1.61$
▲ +15.0% vs prior year% YoY
Net margin
6.6%
▲ +0.1 percentage points vs prior year pp YoY
Revenue▲ +8.4 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +10.0 %
EPS▲ +15.0 %
View financial tableQuarter ended March 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $4.15B | |
| Gross profit | — | |
| Operating income | $514.00M | 12.4 % |
| Net income | $274.00M | 6.6 % |
| R&D | — | |
| EPS (diluted) | 1.61 $ | |
| Balance sheet | ||
| Assets | $29.68B | |
| Liabilities | $23.33B | |
| Equity | $6.35B | |
| Cash | $1.95B | |
| Capital | ||
| Shares outstanding | 166.90M | as of 2026-04-30 |
| Public float | — | |